Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on July 20, 2023. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate development event rather than financial performance data.
Material Changes
The primary material event disclosed is the selection of the Company's subsidiary, BioSig AI Sciences, Inc., to join the NVIDIA Inception program. This announcement was made via a press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this report. The filing includes standard disclaimers that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the press release (Exhibit 99.1) for specific details on the NVIDIA Inception program benefits and timeline.
- Confirm the operational status and strategic role of the subsidiary, BioSig AI Sciences, Inc.
- Review subsequent filings for any updates on the partnership, as the Company disclaims an obligation to update this specific 8-K.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).